SLC27A5 and metabolic dysfunction-associated steatohepatitis: In advanced NASH patients, diminished hepatic FATP5 expression might contribute to the observed hepatic fat loss, positioning FATP5 as one of the genes involved in regulating proteins related to fatty acid metabolism [37].